While most countries produce patents in a healthy spread of technology areas, each country usually has one or two categories in which they specialize. While many countries specialize in high-tech innovation, an increase of visibility around pharmaceutical patent cases draws the focus towards global pharmaceutical innovation.
Pharmaceuticals cover a large portion of patent cases and debates in today’s news. As a tribute to those countries that specialize in the pharmaceutical industry, despite the difficulty it entails, we’ve compiled a list of the Top 5 countries specializing in pharmaceutical patent applications. Ranks are based on the percent of applications which fall under the pharmaceutical category over the past 15 years.
Ranked 11 globally for total number patent applications, India had 23.5% of those falling under the “pharmaceuticals” classification. Two specific companies, Dr. Reddy’s Laboratories Ltd. and Ranbaxy Laboratories Limited, were exceptionally influential towards this number, submitting 26 and 22 publications to the PCT in 2010, respectively.
Krka, D.D., Novo Mesto and LEK Pharmaceuticals D.D. each submitted 24 publications to the PCT in 2010, helping Slovenia to secure second place. With 22.07% of their patent applications being classified as pharmaceutical, Slovenia continues to foster an environment supporting pharmaceutical innovation.
One of Monaco’s main exports is pharmaceuticals, making it no surprise that 20.85% of their patent applications falls into that category. While its mid-low ranking on the overall patent applications list (#78 in 2010) may seem surprising, it remains impressive since Monaco is the second smallest independent state in the world.
Kenya is among the middle ranks of patent applications (#61) as well. Nonetheless, having a sizable 19.51% of its patent applications classified as pharmaceutical makes it a hearty competitor against countries like India, Slovenia, and Monaco.
Embodying the mentality of “The Little Engine that could,” Luxembourg closes out the list with 14.57% of their patent applications belonging to pharmaceuticals. However, it’s noteworthy that such a geographically small country could hold its own with the members of this list.
Wondering why the countries at the head of the IP industry didn’t make the list? Take a look at their statistics regarding patent applications filed under the pharmaceutical classification:
United Kingdom: 7.20%
Other innovative countries, such as Japan, South Korea, Germany, Finland, and South Africa, did not even feature the pharmaceutical category in the top ten for each country!
Check out more Top 5 posts!
Rankings include countries that had sufficient patent statistics through the WIPO to provide a balanced and unbiased analysis.